Kjell E. Öberg

Autoimmunity after Alpha-Interferon Therapy for Malignant Carcinoid Tumors

L Rönnblom, Gunnar V. Alm, Kjell E. Öberg · Annals of Internal Medicine · 1991 · 455 citations

Life Sciences, Immunology, Oncology +17

Possible induction of systemic lupus erythematosus by interferon‐α treatment in a patient with a malignant carcinoid tumour

Lars Rönnblom, Gunnar V. Alm, Kjell E. Öberg · Journal of Internal Medicine · 1990 · 364 citations

Medicine, Immunology, Oncology +14

Chromogranin A and Neuron-Specific Enolase as Prognostic Markers in Patients with Advanced pNET Treated with Everolimus

James C. Yao, Marianne Pavel, Alexandria T. Phan et al. · The Journal of Clinical Endocrinology & Metabolism · 2011 · 226 citations · Full text

Medicine, Oncology, Pharmacology +17

Efficacy and Safety of Prolonged-Release Lanreotide in Patients With Gastrointestinal Neuroendocrine Tumors and Hormone-Related Symptoms

A.N.M. Wymenga, Barbro Eriksson, Pasi Salmela et al. · Journal of Clinical Oncology · 1999 · 223 citations

Medicine, Oncology, Pharmacotherapy +17

Pasireotide (SOM230) shows efficacy and tolerability in the treatment of patients with advanced neuroendocrine tumors refractory or resistant to octreotide LAR: results from a phase II study

Larry K. Kvols, Kjell E. Öberg, Thomas M. O’Dorisio et al. · Endocrine Related Cancer · 2012 · 195 citations · Full text

Medicine, Oncology, Pharmacology +15